Work

Decoding clinical trial jargon: helping people understand theefficacy end points used in cancer trials

Year: 2024

Type: article

Abstract: People living with cancer should have access to clear and comprehensible treatment information to empower informed decision-making. With the increasing adoption of open access publishing and plain-language summaries, clinical trial findings in journals are becoming more accessible. However, this will only help patients if they are equipped with the relevant knowledge and understanding to make sense of these findings. This podcast highlights the need to support this aspect of health literacy by bringing together the perspectives of a patient, a patient advocate and a medical oncologist. It is accompanied by two visual, plain-language guides designed to help general audiences understand the key efficacy end points that are commonly used in trials of solid tumor treatments.

Source: Future Oncology

DOI: 10.1080/14796694.2024.2433411

Authors: Marty Henley, Gissoo DeCotiis, Hannah FitzGibbon, Eric K. Singhi

Institutions: Daiichi Sankyo (Germany), Daiichi-Sankyo (Japan), Daiichi Sankyo (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Health Literacy and Information Accessibility

Subfield: General Health Professions

Field: Health Professions

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funder: Daiichi Sankyo Europe